Drug or treatment

Crizanlizumab clinical trials

As of November 12, 2026, Find a Trial lists 3 clinical trials of Crizanlizumab that are recruiting, at sites in 14 countries (most in Brazil (2), Colombia (2), United States (2)). By phase: Phase 3 (1), Phase 2 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Investigating Crizanlizumab for Sickle Cell Disease in Adolescents and Adults Phase 3 Birmingham, Alabama and 35 other locations Recruiting Jun 3, 2024
Using crizanlizumab alone or with nivolumab for treating advanced glioblastoma and melanoma with brain metastases Phase 2 Ramat Gan, Israel Recruiting Jun 18, 2023
Continuation of crizanlizumab treatment for sickle cell disease patients Phase 4 Birmingham, Alabama and 30 other locations Recruiting Dec 8, 2020

All recruiting trials (3)

Quick answers

How many clinical trials of Crizanlizumab are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 14 countries. The most sites are in Brazil (2 trials), Colombia (2 trials), United States (2 trials), Kenya (1 trial), Uganda (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1, Phase 2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.